Suppr超能文献

慢性乙型肝炎患者中乙型肝炎病毒核心启动子区域的突变

Mutations in the core promoter region of hepatitis B virus in patients with chronic hepatitis B.

作者信息

Kurosaki M, Enomoto N, Asahina Y, Sakuma I, Ikeda T, Tozuka S, Izumi N, Marumo F, Sato C

机构信息

Second Department of Internal Medicine, Tokyo Medical and Dental University, Japan.

出版信息

J Med Virol. 1996 Jun;49(2):115-23. doi: 10.1002/(SICI)1096-9071(199606)49:2<115::AID-JMV8>3.0.CO;2-8.

Abstract

The core promoter region of hepatitis B virus genomes regulates transcription of the precore and pregenomic mRNAs encoding hepatitis B e antigen (HBeAg) and core antigen that contain target epitopes for cytotoxic T lymphocytes. The prevalence and clinical significance of mutations in this region were investigated. DNA was extracted from six asymptomatic carriers positive for HBeAg, eight asymptomatic carriers positive for an anti-HBe antibody, and 24 patients with chronic liver disease. The core promoter and precore regions of hepatitis B virus genomes were amplified by polymerase chain reaction, and predominant sequences were determined by direct sequencing. Mutations were found in none of the HBeAg-positive asymptomatic carriers but in all of the anti-HBe-positive asymptomatic carriers and the patients with chronic liver disease. Especially, A to T mutations at nucleotide 1762 and G to A mutations at nucleotide 1764 were found in five anti-HBe-positive asymptomatic carriers, and 22 patients with chronic liver disease. These two mutation hot spots were located within binding sites of the nuclear factors, and nucleotide 1762 was also involved in the A, T rich sequence that is located 28 base pairs upstream of the precore mRNA initiation site. Serum HBeAg and DNA polymerase levels were significantly lower in patients with these mutations than those without these mutations, and five individuals with these mutations were positive for anti-HBe despite the absence of the precore stop codon mutation. These mutants may be selected by host immune response to HBeAg and/or core antigen.

摘要

乙肝病毒基因组的核心启动子区域调控前核心和前基因组mRNA的转录,这些mRNA编码乙肝e抗原(HBeAg)和核心抗原,而核心抗原包含细胞毒性T淋巴细胞的靶表位。对该区域突变的发生率及其临床意义进行了研究。从6例HBeAg阳性无症状携带者、8例抗-HBe抗体阳性无症状携带者和24例慢性肝病患者中提取DNA。通过聚合酶链反应扩增乙肝病毒基因组的核心启动子和前核心区域,并通过直接测序确定主要序列。在所有HBeAg阳性无症状携带者中均未发现突变,但在所有抗-HBe阳性无症状携带者和慢性肝病患者中均发现了突变。特别是,在5例抗-HBe阳性无症状携带者和22例慢性肝病患者中发现了核苷酸1762处的A到T突变以及核苷酸1764处的G到A突变。这两个突变热点位于核因子的结合位点内,核苷酸1762也参与了在前核心mRNA起始位点上游28个碱基对处的富含A、T的序列。有这些突变的患者血清HBeAg和DNA聚合酶水平显著低于无这些突变的患者,5例有这些突变的个体尽管没有前核心终止密码子突变,但抗-HBe呈阳性。这些突变体可能是由宿主对HBeAg和/或核心抗原的免疫反应所选择的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验